IVC History, Cancer Research
|
|
- Adrian Powell
- 5 years ago
- Views:
Transcription
1 Riordan Clinic IVC Academy 5 IVC History, Cancer Research O (slides 41-80)
2 Pharmacokinetics of Oral Vitamin C using Liposomal Form* To test whether plasma vitamin C levels, following oral doses in supplemented volunteers are tightly controlled and subject to a maximum in the region of 220 mm/l, as suggested by previous researchers for depleted subjects. *Hickey, Roberts, and Miller (unpublished)
3 ??? mm/l Phase 3? 220 mm/l Phase 2 AA is rapidly excreted 70 mm/l Phase 1 AA is actively reabsorbed
4 36 Grams of Liposomal C (Two Subjects) Is This Phase 3 of Vitamin C? (BioCenter Lab 6634 plasma C levels - only 50 > 120 mmol/l) 450 { Phase { { Phase ref. range Phase grL 36grL2
5 450 mm/l Phase 3 Bowel tolerance dosing or frequent liposomal packs 220 mm/l Phase 2 AA is rapidly excreted 70 mm/l Phase 1 AA is actively reabsorbed
6 Dynamic Flow Definition repeated Ascorbic Acid doses, at an interval of less than 5 half-lives, produce a high, steady-state value in blood plasma. Hickey, Roberts, Cathcart J Orthomol Med 2005; 20: Note: Phase 2 Ascorbic Acid halflife is about 30 minutes x 5 = 2.5 hours
7 Applied Dynamic Flow (over extended time) Irwin Stone 1982 letter to Albert Szent- Gyorgyi Nobel Prize winner Joe Kieninger achieved a plasma level of 1817 mm/l 32 mg/dl (USA units) Note: mm/l is Mid-Dose Joe built up to 80 grams of AA/day over a 2½ year period
8 Phase 5 High Dose Intermittent IVC Targeting 10,000 30,000 mm/l Phase 4 Mid-Dose Continuous IVC Target range of mm/l Phase 3 Dynamic Flow Oral Dosing mm/l Phase 2 AA is actively excreted Phase 1 AA is actively reabsorbed
9
10 1 square = growth in 1 week
11 High dose IVC kills tumor cells each treatment. But surviving chemo-resistant cells grow back stronger each time.
12 Low dose, continuous IVC solves the problem of resistant cancer cell selection with intermittent high dose IVC
13 The Yellow Line = continuous recovery. Intermittent IVC controls cancer, but often does not defeat cancer.
14 Mid-Dose-Continuous-IVC can also be AUGMENTED with standard Riordan Protocol Dosage infusions. Hybrid IVC high dose mid
15 Effects of human serum removed from patient before and at intervals after intravenous infusion of vitamin C (60 grams) on cultured human prostate tumor cells Survival % (bars) Serum ascorbate (mg/dl) (line) T=0 T=35 T=65 T=95 T=125 T=185 T=245 T=305 Time (minutes) 0
16 Mid-Dose-Continuous IVC will spark a continuously positive rate of chronic illness recovery by imitating the way ascorbate is made in injured animals
17 Tumor Inhibition by Vitamin C (animal studies) 10 Clin Cancer Res January 15; 16(2): Surviving Animals Ascorbate Control Time (days) Survival time of sarcoma bearing mice control and treated with IP ascorbate 700 mg/kg
18 Effect of Ascorbic Acid on Angiogenesis Ascorbic acid inhibits migration and angiogenesis of the endothelial cells. AA at 1-3 mg/ml caused the reduction of the growth of sprouts from aortic rings. Mikirova NA, Casciari JJ, Riordan NH. Ascorbate inhibition of angiogenesis in aortic rings ex vivo and subcutaneous Matrigel plugs in vivo. Journal of Angiogenesis Research 2010, 2:2
19 Ascorbic Acid is Amazing dosing is crucial! Corrects scurvy in cancer patients (less fatigue) Supports detoxification systems in the body Relieves pain and promotes well-being Boosts cellular immunity (to prevent secondary infections) Stimulates collagen formation (to wall off tumor) Inhibits hyaluronidase (to retard metastasis) Relieves cellular hypoxia/restores aerobic metabolism Restores mitochondrial functioning, improves apoptosis Inhibits angiogenesis and reduces tumor nutrient supply Potentiates chemotherapy and radiation Reduces side effects & toxicity of conventional therapy Plausible oncologic adjunct in cancer patient care
20 Effects of IVC on Inflammation
21 Inflammation and Cancer Inflammation is a critical component of tumor progression. Cancers arise from sites of chronic injury. Inflammatory component is present and contributes to tumor proliferation angiogenesis metastasis resistance to chemotherapy. Nature December 19; 420, 6917
22 The Seven Hallmarks of Cancer 1. Self-sufficiency of growth signals 2. Insensitivity to antigrowth signals 3. Evasion of apoptosis 4. Unlimited proliferation potential 5. Enhanced angiogenesis 6. Tissue invasion and metastasis 7. Inflammatory microenvironment Molecular Cancer Research; 4(4). April 2006
23 Cytokines, inflammation and tumor growth Tumors that produce little or no cytokines induce limited inflammatory and vascular responses, resulting in constrained tumor growth. In contrast, production of an abundance of pro-inflammatory cytokines potentiates angiogenesis, thus favoring neoplastic growth. Nature December 19; 420(6917), Coussens et al.
24 Effect of high-dose intravenous vitamin C on inflammation in cancer patients. The high dose intravenous ascorbic acid therapy affects C-reactive protein levels and pro-inflammation cytokines in cancer patients. Modulation of inflammation by IVC correlated with decreases in tumor marker levels. Mikirova et al. Journal of Translational Medicine 2012, 10:189
25 Inflammation: a driving force of cancer metastasis Inflammatory cells produce TNFα, TGFβ, IL-6, IL-1 activate NFκB STAT3 pathways induce epithelial-to-mesenchymal transition (EMT) and metastasis. Wu Y et al. Cell Cycle 8:20, ; October 15, 2009
26 CRP in Inflammation and Cancer Patients with increased CRP had a higher risk of dying from cancer than from other causes independent of acute infection. The relation of CRP to cancer death was stronger than to vascular death. Clinical Chemistry 54:2, , 2008, Claudia Marsik et al
27 CRP a Prognostic Indicator CRP Predicts Cancer Survival in Multiple myeloma Melanoma Lymphoma Ovarian Ca Renal Ca Pancreatic Ca GI Cancers Prostate ca Mahmoud FA, Rivera NI. Current Oncology Report 2002;4:250 5
28 Does high dose IVC therapy suppress inflammation in cancer patients? Patients followed the Riordan IVC Protocol IVC doses ranged from 7.5 g 50 g Median follow-up time was 7.2 years CRP and tumor markers were measured as a routine analysis Pro-inflammatory cytokines were measured before and after IVC
29 CRP values before and after IVC treatments Most of the cancer patients, 70 ± 13 % showed a reduction in CRP during IVC therapy.
30 Serum C-Reactive Protein as Independent Prognostic Variable Kaplan-Meier curves for overall survival of patients with ovarian cancer broken down by serum CRP. Hefer et al. Clin Cancer Res 2008;14(3): 210
31 The Effects of IVC on PSA
32 The effects of IVC therapy on PSA 70 % of patients showed reduced PSA levels during IVC treatment. Mikirova et al. 2015
33 Tracking of PSA levels over time in subjects with prostate cancer Subject A: initial Gleason score =6; treatments given weekly or twice weekly at doses of 25 g; PSA levels decreased from initial values of 60 ng/ml to final values in the normal range. Subject B: Gleason score = 6 9; treatments typically given weekly at doses of either 7.5 g or 25 g (40 IVC); PSA levels decreased from maximum values of 1500 ng/ml to a final value of 7 ng/ml.
34 Tracking of PSA levels over time in subjects with prostate cancer Subject A: initial Gleason score =6; treatments given weekly or twice weekly at doses of 25 g; PSA levels decreased from initial values of 60 ng/ml to final values in the normal range. Subject B: Gleason score = 6 9; treatments typically given weekly at doses of either 7.5 g or 25 g (40 IVC); PSA levels decreased from maximum values of 1500 ng/ml to a final value of 7 ng/ml.
35 PSA IVC (grams C) Changes of the rate of PSA progression during IVC treatment PSA IVC (grams C) PSA frequency IVC ra te of change IVC frequency of IVC rate of chang e PSA days 40 IVC d ays DAYS days
36 The effect of IVC on the suppression of ALP As ALP is a marker of bone formation and the most often site of metastasis for prostate cancer patients is bone, the analysis of the ALP may be helpful tools to evaluate the effectiveness of the IVC therapy on metastatic site. 140 ALP PSA IVC ALP (U/L) PSA (ng/ml) Vitamin C (grams-ivc) Vitamin C (grams - Chelation) ALP PSA ALP days DAYS
37 Effect of IVC on Bone Regeneration
38 Effect of vitamin C on bone regeneration AA deficiency inhibits bone formation osteoblasts differentiation bone matrix growth Immunohistochemical analyses of collagen I (a, b), and osteoblast cells. Urban et al. Head & Face Medicine 2012, 8:25
39 Effect of IVC on Cell Signaling
40 Unified Theory Of Sustained Reserves Illness Depletion Adapted eos External Oxidative Stress ios internal Oxidative Stress Genetic Expression Repair Damage DNA Membranes AOS Structural ROS Signaling Chemical
41 Cellular Injury Inadequate nutrient reserves The damage cannot be repaired Cytokine Signaling Cytokine signaling intensifies the inflammatory response
IVC History, Cancer Research
Riordan Clinic IVC Academy 5 IVC History, Cancer Research O (slides 1 40) Riordan Clinic 2018 High Dose Vitamin C Adjunctive Care for Cancer Patients IVC and Cancer Research Overview History & Research
More informationIVC. Three Key. Lectures IVC & IVC & Cancer Care. Mitochondrial Energy. IVC: Nature s Remedy for Chronic Disease
IVC IVC & Cancer Care IVC & Three Key Lectures Mitochondrial Energy IVC: Nature s Remedy for Chronic Disease Intravenous Vitamin C 1. IVC and Cancer Care Cancer Care Ron Hunninghake, MD Chief Medical Officer
More informationIVC History, Cancer Research
Riordan Clinic IVC Academy 5 IVC History, Cancer Research O (slides 81-116) Cytokine Signaling Categories Heal the Wound! Angiogenesis - 62 Inflammation - 69 Differentiation - 53 Oncogene-Activation -
More informationA holistic approach to targeting breast cancer part II: Micronutrient synergy. Presented by: Dr. Neha Shanker DRRI
A holistic approach to targeting breast cancer part II: Micronutrient synergy Presented by: Dr. Neha Shanker DRRI Overview of the previous webinar In the last presentation we talked about: Increase in
More informationSPECIAL REPORT. by Dr. Mark Stengler.
SPECIAL REPORT by Dr. Mark Stengler www.markstengler.com All rights reserved. This program, or parts thereof, may not be reproduced in any form without permission in writing from the author. Copyright
More informationThe Hallmarks of Cancer
The Hallmarks of Cancer Theresa L. Hodin, Ph.D. Clinical Research Services Theresa.Hodin@RoswellPark.org Hippocrates Cancer surgery, circa 1689 Cancer Surgery Today 1971: Nixon declares War on Cancer
More informationCELL BIOLOGY - CLUTCH CH CANCER.
!! www.clutchprep.com CONCEPT: OVERVIEW OF CANCER Cancer is a disease which is primarily caused from misregulated cell division, which form There are two types of tumors - Benign tumors remain confined
More informationBiobehavioral Pathways in Epithelial Ovarian Cancer
Biobehavioral Pathways in Epithelial Ovarian Cancer Susan K. Lutgendorf, Ph.D. Departments of Psychology, Obstetrics and Gynecology, and Urology and Holden Comprehensive Cancer Center University of Iowa
More informationConvergent and Divergent Mechanisms in Aging and Cancer
Convergent and Divergent Mechanisms in Aging and Cancer Mariana S. De Lorenzo, PhD Department of Cell Biology & Molecular Medicine delorems@umdnj.edu LEARNING OBJECTIVES 1. To identify convergent and divergent
More informationBY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY
BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY Cancer is a group of more than 100 different diseases that are characterized by uncontrolled cellular growth,
More informationA PHASE 1 STUDY OF TRC105 (ANTI- ADVANCED SOLID TUMORS
ASCO 2011 Abstract Number: 3073 A PHASE 1 STUDY OF TRC105 (ANTI- CD105 ANTIBODY) IN PATIENTS WITH ADVANCED SOLID TUMORS J. W. Goldman, M. S. Gordon, H. Hurwitz, R. Pili, D. S. Mendelson, B. J. Adams, D.
More informationOMICS Journals are welcoming Submissions
OMICS Journals are welcoming Submissions OMICS International welcomes submissions that are original and technically so as to serve both the developing world and developed countries in the best possible
More informationInflammatory Cells and Metastasis
Inflammatory Cells and Metastasis Experimentelle Krebsforschung SS 07 Gerhard Christofori Institute of Biochemistry and Genetics Department of Clinical-Biological Sciences Center of Biomedicine University
More informationTissue renewal and Repair. Nisamanee Charoenchon, PhD Department of Pathobiology, Faculty of Science
Tissue renewal and Repair Nisamanee Charoenchon, PhD Email: nisamanee.cha@mahidol.ac.th Department of Pathobiology, Faculty of Science Topic Objectives 1. Describe processes of tissue repair, regeneration
More informationInhibitors of Methionine Aminopeptidase-2 2 in the Treatment of Non-Hodgkin
Inhibitors of Methionine Aminopeptidase-2 2 in the Treatment of Non-Hodgkin Hodgkin s s Lymphoma Targeted Cancer Therapies William Westlin, Ph.D. Vice President, Preclinical Research Discovery of Fumagillin
More informationIL-24 AND ITS ROLE IN WOUND HEALING
IL-24 AND ITS ROLE IN WOUND HEALING Nancy J. Poindexter, Ryan Williams, Garth Powis, Sunil Chada, and Elizabeth A. Grimm & Introgen Therapeutics, Inc., Houston, TX IL-24/MDA 24/MDA-77 is a Tumor Suppressor
More informationCell Death and Cancer. SNC 2D Ms. Papaiconomou
Cell Death and Cancer SNC 2D Ms. Papaiconomou How do cells die? Necrosis Death due to unexpected and accidental cell damage. This is an unregulated cell death. Causes: toxins, radiation, trauma, lack of
More informationSupplementary Figure 1. Deletion of Smad3 prevents B16F10 melanoma invasion and metastasis in a mouse s.c. tumor model.
A B16F1 s.c. Lung LN Distant lymph nodes Colon B B16F1 s.c. Supplementary Figure 1. Deletion of Smad3 prevents B16F1 melanoma invasion and metastasis in a mouse s.c. tumor model. Highly invasive growth
More informationVit C Cases - Shingles
Vit C Cases - Shingles Schencking M, Sandholzer H, Frese T. Intravenous administration of vitamin C in the treatment of herpetic neuralgia: two case reports. Med Sci Monit. 2010 Apr 28;16(5):CS58-61. PubMed
More informationGene expression profiling predicts clinical outcome of prostate cancer. Gennadi V. Glinsky, Anna B. Glinskii, Andrew J. Stephenson, Robert M.
SUPPLEMENTARY DATA Gene expression profiling predicts clinical outcome of prostate cancer Gennadi V. Glinsky, Anna B. Glinskii, Andrew J. Stephenson, Robert M. Hoffman, William L. Gerald Table of Contents
More informationSinge Institutional Experiences With Intravenous Viscum Album PRESENTED BY: ERIC MARSDEN BSC ND
Singe Institutional Experiences With Intravenous Viscum Album PRESENTED BY: ERIC MARSDEN BSC ND Disclosure & Thanks I am an owner of a healthcare center that provides supportive naturopathic care for cancer
More informationCancer Cell Self Sufficiency in Growth Signals
Name Date Cancer Cell Self Sufficiency in Growth Signals Part 1: Introduction Read the introduction. Draw a flower in the box when finished with this step. RAS Diagram Use the space below the diagram to
More informationBIOLOGY OF CANCER. Definition: Cancer. Why is it Important to Understand the Biology of Cancer? Regulation of the Cell Cycle 2/13/2015
BIOLOGY OF CANCER Why is it Important to Understand the Biology of Cancer? Cynthia Smith, RN, BA, MSN, AOCN Oncology Clinical Nurse Specialist Harrison Medical Center Definition: Cancer Regulation of the
More informationCancer and Oncogenes Bioscience in the 21 st Century. Linda Lowe-Krentz
Cancer and Oncogenes Bioscience in the 21 st Century Linda Lowe-Krentz December 1, 2010 Just a Few Numbers Becoming Cancer Genetic Defects Drugs Our friends and family 25 More mutations as 20 you get older
More informationLecture 1: Carcinogenesis
Lecture 1: Carcinogenesis Anti-cancer (oncology agents): These are perhaps the most dangerous of drugs, other than the narcotic analgesics. This is due to their toxicities. Killing or inhibiting cancer
More informationGcMAF for the treatment of cancer, autism, inflammation, viral and bacterial disease
GcMAF for the treatment of cancer, autism, inflammation, viral and bacterial disease by David Noakes David Noakes Human GcMAF, otherwise known as Vitamin D binding protein macrophage activating factor,
More informationCancer Biology How a cell responds to DNA Damage
1 Cancer Biology How a cell responds to DNA Damage Jann Sarkaria Department of Oncology Mayo Clinic 2 EDUCATIONAL GOALS How proteins can transmit signals to each other. The definition of a tumor suppressor
More informationChapter 20 Lecture Outline
Chapter 20 Lecture Outline See separate PowerPoint slides for all figures and tables preinserted into PowerPoint without notes. Copyright 2016 McGraw-Hill Education. Permission required for reproduction
More informationNovel RCC Targets from Immuno-Oncology and Antibody-Drug Conjugates
Novel RCC Targets from Immuno-Oncology and Antibody-Drug Conjugates Christopher Turner, MD Vice President, Clinical Science 04 November 2016 Uveal Melanoma Celldex Pipeline CANDIDATE INDICATION Preclinical
More informationDr. Atsuo Yanagisawa President Japanese College of Intravenous Therapy International Society for Orthomolecular Medicine
Intravenous Vitamin C Therapy In Japan Dr. Atsuo Yanagisawa President Japanese College of Intravenous Therapy International Society for Orthomolecular Medicine 1 Dr. Atsuo Yanagisawa, MD, PhD Director
More informationNASH Bench to Bedside
NASH Bench to Bedside October 2006 Anna Mae Diehl, M.D. Gastroenterology Division Duke University NonAlcoholic Fatty Liver Disease Common ~1/4-1/3 1/3 US adults Outcome highly variable Course indolent
More informationLAG-3: Validation Of Next Generation Checkpoint Pathways
LAG-3: Validation Of Next Generation Checkpoint Pathways Frédéric Triebel, CO/CMO Immune Checkpoint Modulation & Combination Therapies April 13, 2016 London, UK. 1 AX:PRR; NADAQ:PBMD Notice: Forward Looking
More informationChapter 10-3 Regulating the Cell Cycle
Chapter 10-3 Regulating the Cell Cycle Vocabulary: Cyclin Cancer Key Concepts: How is the cell cycle regulated? How are cancer cells different from other cells? I. Introduction A. An Interesting Fact About
More informationDr Hugh Riordan Vitamin C Maverick. Slides 1-45
Riordan Clinic IVC Academy Dr Hugh Riordan Vitamin C Maverick O Slides 1-45 Riordan Clinic 2018 Dr. Hugh Riordan Vitamin C Maverick Ron Hunninghake M.D. Chief Medical Officer Riordan Clinic One man with
More informationLecture 1: Carcinogenesis
Lecture 1: Carcinogenesis Anti-cancer (oncology agents): These are perhaps the most dangerous of drugs, other than the narcotic analgesics. This is due to their toxicities. Killing or inhibiting cancer
More informationBihong Zhao, M.D, Ph.D Department of Pathology
Bihong Zhao, M.D, Ph.D Department of Pathology 04-28-2009 Is tumor self or non-self? How are tumor antigens generated? What are they? How does immune system respond? Introduction Tumor Antigens/Categories
More informationTofacitinib ( Xeljanz) Marshall Porter & Lauren Ysais
Tofacitinib ( Xeljanz) Marshall Porter & Lauren Ysais Learning Objectives to Take with You A small molecule Janus Kinase (JAK) Inhibitor treatment for moderate to severe rheumatoid arthritis (RA) reduces
More informationProgressive Peptide Therapy. Kathleen O Neil Smith, MD, FAARM Treat Wellness LLC Newton, MA
Progressive Peptide Therapy Kathleen O Neil Smith, MD, FAARM Treat Wellness LLC Newton, MA Disclosure Statement!I do not have any affiliations or financial arrangements with any commercial entities whose
More informationImmune Checkpoint Inhibitors: The New Breakout Stars in Cancer Treatment
Immune Checkpoint Inhibitors: The New Breakout Stars in Cancer Treatment 1 Introductions Peter Langecker, MD, PhD Executive Medical Director, Global Oncology Clinipace Worldwide Mark Shapiro Vice President
More informationCorporate Overview June 2014 Jefferies Healthcare Conference NASDAQ: GLYC
Corporate Overview June 2014 Jefferies Healthcare Conference NASDAQ: GLYC Forward-Looking Statements To the extent that statements contained in this presentation are not descriptions of historical facts
More informationFlavonoids. PHRI Bio-Tech Sdn All rights reserved 1
Flavonoids PHRI Bio-Tech Sdn Bhd @ 2014. All rights reserved 1 Ari Bergwerk, MD Intravenous apply of Flavonoids and Ascorbic Acid as a Clinical Treatment of Post-Menopausal Syndrome. Consultant Geriatrician
More informationCancer and Oncogenes Bioscience in the 21 st Century. Linda Lowe-Krentz October 11, 2013
Cancer and Oncogenes Bioscience in the 21 st Century Linda Lowe-Krentz October 11, 2013 Just a Few Numbers Becoming Cancer Genetic Defects Drugs Our friends and family 200 180 160 140 120 100 80 60 40
More informationThe Galectin-3 Inhibitor GR-MD-02 for Combination Cancer Immunotherapy
The Galectin-3 Inhibitor GR-MD-02 for Combination Cancer Immunotherapy Supplemental Information to Corporate Presentation February 6, 2018 NASDAQ: GALT www.galectintherapeutics.com 2018 2017 Galectin Therapeutics
More informationPREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland
AD Award Number: W81XWH-1-1-176 TITLE: Suppression of BRCA2 by Mutant Mitochondrial DNA in Prostate Cancer PRINCIPAL INVESTIGATOR: Hsieh, Jer-Tsong CONTRACTING ORGANIZATION: University of Texas Southwestern
More informationChapter 1: Curcumin is excellent compound for various medicinal usages
Super-Curcumin Story Chapter 1: Curcumin is excellent compound for various medicinal usages Chapter 2: Discovery of Super-Curcumin analog Chapter 3: Anti-tumor activities of Super-Curcumin analog Chapter
More informationI TESSUTI: Dott.ssa Liliana Belgioia Università degli Studi di Genova
I TESSUTI: 1. Repair, Radiosensitivity, Recruitment, Repopulation, Reoxygenation 2. Acute and chronic hypoxia 3. Tissue microenvironment and tissue organization Dott.ssa Liliana Belgioia Università degli
More informationBone Metastases. Sukanda Denjanta, M.Sc., BCOP Pharmacy Department, Chiangrai Prachanukroh Hospital
Bone Metastases Sukanda Denjanta, M.Sc., BCOP Pharmacy Department, Chiangrai Prachanukroh Hospital 1 Outline Pathophysiology Signs & Symptoms Diagnosis Treatment Spinal Cord Compression 2 General Information
More informationONCOGENESIS A multistep process comprised of
by Dr JO Serrentino The seminar/webinar is for the purposes of continuing education and available to registrants only. No part of this material may be duplicated in any format without the expressed written
More informationEarly Embryonic Development
Early Embryonic Development Maternal effect gene products set the stage by controlling the expression of the first embryonic genes. 1. Transcription factors 2. Receptors 3. Regulatory proteins Maternal
More informationOral vs. Intravenous Vitamin C Ronald Hunninghake, MD
Oral vs. Intravenous Vitamin C Optimizing the Use of Vitamin C in the Care of Cancer Patients Cancer is a word, not a sentence. - John Diamond Ron Hunninghake, MD Chief Medical Officer The Olive W. Garvey
More informationBiological Therapies for Cancer: Questions and Answers
Biological Therapies for Cancer: Questions and Answers Key Points Biological therapies use the body s immune system to fight cancer or to lessen the side effects that may be caused by some cancer treatments
More informationCoQ10 and Cancer Treatment
http://www.lef.org/ Life Extension Magazine September 2009 CoQ10 and Cancer Treatment By William Faloon For more than a decade, Life Extension has reported on small clinical studies that demonstrate beneficial
More informationTargeted Chemoprevention of Progressive Marrow Failure in Patients with Fanconi Anemia using Quercetin, a Pilot study
Targeted Chemoprevention of Progressive Marrow Failure in Patients with Fanconi Anemia using Quercetin, a Pilot study Parinda Mehta, M.D. Division of Bone Marrow Transplantation and Immune Deficiency Cincinnati
More informationType of file: PDF Size of file: 0 KB Title of file for HTML: Supplementary Information Description: Supplementary Figures
Type of file: PDF Size of file: 0 KB Title of file for HTML: Supplementary Information Description: Supplementary Figures Supplementary Figure 1 mir-128-3p is highly expressed in chemoresistant, metastatic
More informationweb.mit. edu/
Cancer Due to Prolonged Inflammation Nithya Lingampalli B S J Inflammation has long been accepted as the most standard, and perhaps the most effective, response that the body has in place to fight both
More informationCancer Genetics. What is Cancer? Cancer Classification. Medical Genetics. Uncontrolled growth of cells. Not all tumors are cancerous
Session8 Medical Genetics Cancer Genetics J avad Jamshidi F a s a U n i v e r s i t y o f M e d i c a l S c i e n c e s, N o v e m b e r 2 0 1 7 What is Cancer? Uncontrolled growth of cells Not all tumors
More informationGFP Assays
GFP Assays 2009-07-03 GFP Assays Akt1 SMAD2 STAT3 NFAT-C1 MAPKAP-k2 Rac-1 PLCδ PH domain FYVE G2M CCPM Cell survival, proliferation, apoptosis, insulin response pathways TGF-beta signalling, growth, differentiation,
More informationDevelopment of a Novel IL-12 DNA-based Immunotherapy in Combination with Chemotherapy for Treatment of Advanced Ovarian Cancer
Development of a Novel IL-12 DNA-based Immunotherapy in Combination with Chemotherapy for Treatment of Advanced Ovarian Cancer Khursheed Anwer, Ph.D. Executive Vice President and CSO Molecular Medicine
More informationAdvanced Pathophysiology Unit 7: Renal-Urologic Page 1 of 6
Advanced Pathophysiology Unit 7: Renal-Urologic Page 1 of 6 Learning Objectives for this File: 1. Understand how clinical presentation drives the diagnostic workup 2. Recognize how patient education is
More informationOncolytic Viruses: Reovirus
T S X : O N C N A S D A Q : O N C Y International Society for Biological Therapy of Cancer 2008 Oncology Biologics Development Primer Oncolytic Viruses: Reovirus REOLYSIN - mode of action REOLYSIN contains
More informationEvaluation of STAT3 Signaling in Macrophages Using a Lentiviral Reporter System
Evaluation of STAT3 Signaling in Macrophages Using a Lentiviral Reporter System Schwertfeger Laboratory Emily Hartsough Breast Cancer Prevalence Adapted from Siegel et. al Cancer Statistics. 2016 Tumor
More informationExplaining Personalized Medicine in Cancer and Some Tips for a Healthier Life. Petra Ketterl, MD Integrative Medicine and Cancer Care
Explaining Personalized Medicine in Cancer and Some Tips for a Healthier Life Petra Ketterl, MD Integrative Medicine and Cancer Care Personalized Medicine in General A type of medical care in which treatment
More informationThe Effect of High Dose IV Vitamin C on Plasma Antioxidant Capacity and Level of Oxidative Stress in Cancer Patients and Healthy Subjects
The Effect of High Dose IV Vitamin C on Plasma Antioxidant Capacity and Level of Oxidative Stress in Cancer Patients and Healthy Subjects N.A Mikirova, Ph.D.; J.A. Jackson, Ph.D., MT(ASCP); Neil H Riordan,
More informationImmunohistochemistry in Bone and Soft Tissue Tumors. Sahar Rassi Zankoul, MD
Immunohistochemistry in Bone and Soft Tissue Tumors Sahar Rassi Zankoul, MD Introduction Bone tumors represent a wide variety of tumors of various origins and malignant potentials. These different tumor
More informationmir-509-5p and mir-1243 increase the sensitivity to gemcitabine by inhibiting
mir-509-5p and mir-1243 increase the sensitivity to gemcitabine by inhibiting epithelial-mesenchymal transition in pancreatic cancer Hidekazu Hiramoto, M.D. 1,3, Tomoki Muramatsu, Ph.D. 1, Daisuke Ichikawa,
More informationConnections Between Autoimmune Disease & Cancer
February 6, 2018 Connections Between Autoimmune Disease & Cancer Dr. Reetesh Bose, PGY2 Supervisor: Dr. Jennifer Beecker, MD, CCFP(EM), FRCPC, DABD, FAAD University of Ottawa, Division of Dermatology Definitions
More informationCollection of Recorded Radiotherapy Seminars
IAEA Human Health Campus Collection of Recorded Radiotherapy Seminars http://humanhealth.iaea.org Conservative Treatment of Invasive Bladder Cancer Luis Souhami, MD Professor Department of Radiation Oncology
More informationOncology 101. Cancer Basics
Oncology 101 Cancer Basics What Will You Learn? What is Cancer and How Does It Develop? Cancer Diagnosis and Staging Cancer Treatment What is Cancer? Cancer is a group of more than 100 different diseases
More informationbreast and OVARIAN cancer
breast and OVARIAN cancer DR DAVID FENNELLY CONSULTANT MEDICAL ONCOLOGIST ST VINCENT S UNIVERSITY HOSPITAL DUBLIN HOW RELEVANT IS ONCOLOGY IN MEDICINE TODAY? Cancer is the second leading cause of death
More informationNursing s Role in the Management of New Oral Chemotherapy Agents
Nursing s Role in the Management of New Oral Chemotherapy Agents Mechelle Barrick BSN, RN, OCN, CCRP Clinical Research Nurse Coordinator Greater Baltimore Medical Center mbarrick@gbmc.org THE NURSES ROLE
More informationAccelerate Your Research with Conversant Bio
Accelerate Your Research with Conversant Bio 400+ Participating MDs 50+ Partner sites for tissue procurement Continuous expansion of sourcing capabilities Closely monitored chain of custody Full regulatory
More informationVIII Curso Internacional del PIRRECV. Some molecular mechanisms of cancer
VIII Curso Internacional del PIRRECV Some molecular mechanisms of cancer Laboratorio de Comunicaciones Celulares, Centro FONDAP Estudios Moleculares de la Celula (CEMC), ICBM, Facultad de Medicina, Universidad
More information1.The metastatic cascade. 2.Pathologic features of metastasis. 3.Therapeutic ramifications
Metastasis 1.The metastatic cascade 2.Pathologic features of metastasis 3.Therapeutic ramifications Sir James Paget (1814-1899) British Surgeon/ Pathologist Paget s disease of bone Paget s disease of the
More informationIVC - Clinical Implementation
Riordan Clinic IVC Academy 8 IVC - Clinical Implementation O IVC In Your Office Clinical Implementation 1. Patient Selection 2. Adverse Reactions 3. Mixing/Administration 4. Drug Interactions 5. Monitoring
More informationProstate Case Scenario 1
Prostate Case Scenario 1 H&P 5/12/16: A 57-year-old Hispanic male presents with frequency of micturition, urinary urgency, and hesitancy associated with a weak stream. Over the past several weeks, he has
More informationTargeting tumour associated macrophages in anti-cancer therapies. Annamaria Gal Seminar Series on Drug Discovery Budapest 5 January 2018
Targeting tumour associated macrophages in anti-cancer therapies Annamaria Gal Seminar Series on Drug Discovery Budapest 5 January 2018 Macrophages: Professional phagocytes of the myeloid lineage APC,
More informationNew Anticancer Agents Targeting the Tumor-Specific Microenvironment (OTT ID 1277)
New Anticancer Agents Targeting the Tumor-Specific Microenvironment (OTT ID 1277) Inventor: Xiaohua Peng, Associate Professor, Department of Chemistry and Biochemistry UW-Milwaukee For further information
More informationNational Horizon Scanning Centre. Aflibercept (VEGF Trap) for advanced chemo-refractory epithelial ovarian cancer. December 2007
Aflibercept (VEGF Trap) for advanced chemo-refractory epithelial ovarian cancer December 2007 This technology summary is based on information available at the time of research and a limited literature
More informationPosters and Presentations
Posters and Presentations June 2017: American Society of Clinical Oncology (ASCO) Annual - Preliminary Correlative Analysis of PD-L1 expression from the SUNRISE Study. View April 2017: American Association
More informationTransformation of Normal HMECs (Human Mammary Epithelial Cells) into Metastatic Breast Cancer Cells: Introduction - The Broad Picture:
Transformation of Normal HMECs (Human Mammary Epithelial Cells) into Metastatic Breast Cancer Cells: Introduction - The Broad Picture: Spandana Baruah December, 2016 Cancer is defined as: «A disease caused
More informationCRYOSENSITIZERS: Ablation at the Edge
CRYOSENSITIZERS: Ablation at the Edge John G. Baust Institute of Biomedical Technology State University of New York Binghamton, NY USA JGBaust@binghamton.edu Precision targeting Challenge Uncertain margin
More informationCirculating tumor cells/dna/etc for Radiation Oncologists
Circulating tumor cells/dna/etc for Radiation Oncologists Andrew Z. Wang, M.D. Associate Professor Director of Clinical and Translational Research Department of Radiation Oncology Carolina Center for Cancer
More informationCANCER IMMUNOPATHOLOGY. Eryati Darwin Faculty of Medicine Andalas University
CANCER IMMUNOPATHOLOGY Eryati Darwin Faculty of Medicine Andalas University Padang 18 Mei 2013 INTRODUCTION Tumor: cells that continue to replicate, fail to differentiate into specialized cells, and become
More informationCancer Biology Course. Invasion and Metastasis
Cancer Biology Course Invasion and Metastasis 2016 Lu-Hai Wang NHRI Cancer metastasis Major problem: main reason for killing cancer patients, without it cancer can be cured or controlled. Challenging questions:
More informationNew Biological and Immunological Therapies for Cancer
New Biological and Immunological Therapies for Cancer Sant P. Chawla, M.D., FRACP The Sarcoma Oncology Center, Santa Monica CA 90403 7 th International Conference on Drug Discovery &Therapy 1 Promising
More informationXgeva (denosumab) injection, for subcutaneous use Initial US Approval: 2010
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use XGEVA safely and effectively. See full prescribing information for XGEVA. Xgeva (denosumab) injection,
More informationAntitumor Activity of CUDC-305, a Novel Oral HSP90 Inhibitor, in Solid and Hematological Tumor Xenograft Models
Antitumor Activity of CUDC-5, a Novel Oral HSP Inhibitor, in Solid and Hematological Tumor Xenograft Models Rudi Bao, MD/PhD April 1, 2 AACR 1th Annual Meeting 2 Experimental and Molecular Therapeutics
More informationJournal Club WS 2012/13 Stefanie Nickl
Journal Club WS 2012/13 Stefanie Nickl Background Mesenchymal Stem Cells First isolation from bone marrow 30 ys ago Isolation from: spleen, heart, skeletal muscle, synovium, amniotic fluid, dental pulp,
More informationOncolytic Virotherapy: Targeting Cancer Stem Cells
Oncolytic Virotherapy: Targeting Cancer Stem Cells Cancer Stem Cells (CSCs) or Cancer Initiating Cells (CICs) A consensus of five defining criteria has been established to affirm the existence of CICs:
More informationBRIDGE THE GAP A Human Pathways Approach to Disease Research
BRIDGE THE GAP A Human Pathways Approach to Disease Research BIOMED 21 Brussels December 8 th, 2015 Brigitte Landesmann Systems Toxicology Unit and EURL ECVAM Institute for Health and Consumer Protection
More informationClinical: Ipilimumab (MDX-010) Update and Next Steps
Clinical: Ipilimumab (MDX-010) Update and Next Steps Geoffrey M. Nichol, M.D., M.B.A. Senior Vice President, Product Development Medarex, Inc. R&D Day December 9, 2005 Ipilimumab: New Class of Cancer Therapy
More informationSeeds and soil theory by Stephen Paget at the end of the XIX century.
Seeds and soil theory by Stephen Paget at the end of the XIX century. In The Distribution Of Secondary Growths In Cancer Of The Breast Paget presents and analyzes 735 fatal cases of breast cancer, complete
More informationAdvanced Prostate Cancer. November Jose W. Avitia, M.D
Advanced Prostate Cancer November 4 2017 Jose W. Avitia, M.D In 2017 161,000 new cases of prostate cancer diagnosed in US, mostly with elevated PSA 5-10% will present with metastatic disease In 2017: 26,000
More informationCancer arises from the mutation of a normal gene. A factor which brings about a mutation is called a mutagen.
Cancer Single cells divide by mitosis to form many cells. This cells undergo physical and chemical changes in order to perform specific functions. (we say the cells have Differentiated) in this way we
More informationImpact of vitamin C on genistein-induced cell death in prostate cancer. Toluleke Oloruntobi Famuyiwa 09/20/2015
Impact of vitamin C on genistein-induced cell death in prostate cancer 1 st Electronic Conference on Molecular Science Toluleke Oloruntobi Famuyiwa 09/20/2015 Introduction Stages of Prostate Cancer Key
More informationImmune Checkpoints. PD Dr med. Alessandra Curioni-Fontecedro Department of Hematology and Oncology Cancer Center Zurich University Hospital Zurich
Immune Checkpoints PD Dr med. Alessandra Curioni-Fontecedro Department of Hematology and Oncology Cancer Center Zurich University Hospital Zurich Activation of T cells requires co-stimulation Science 3
More informationStyle of practice (1) Private clinic 77 % (282) Hospital 21 % ( 46 ) Others 2 % ( 11 ) Style of practice (2)
Style of practice (1) Private clinic 77 % (282) Hospital 21 % ( 46 ) Others 2 % ( 11 ) Style of practice (2) Oncologist (standard treatment) 4 % ( 14 ) Oncologist (non-standard) 5 % ( 17 ) Non-oncologist
More informationTOPICS. Primary Radiation Therapy. Targeted Therapy in Oncology. Principles of Radiation Therapy. Principles of Radiation Therapy
Peter B. Schiff, M.D., Ph.D. Department of Radiation Oncology Columbia University College of Physicians & Surgeons May 4, 2007 Targeted Therapy in Oncology Surgical Oncology Minimal invasive techniques
More informationLabor Dr. Gansauge Sedanstraße, Ulm
Labor Dr. Gansauge Sedanstraße, Ulm 3 3 LANEX-DC Immunotherapy with dendritic cells The ability to fight cancer using one s own immune system has been a great dream of medical scientists for centuries.
More informationBone Marrow Transplantation
Bone Marrow Transplantation Introduction Bone marrow is the spongy tissue inside all of your bones, including your hip and thigh bones. The bone marrow is like a factory that makes different types of blood
More information